Item Type | Name |
Academic Article
|
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
|
Academic Article
|
Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
|
Academic Article
|
Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation.
|
Academic Article
|
Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension.
|
Academic Article
|
Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.
|
Academic Article
|
Histopathology of pulmonary hypertension.
|
Academic Article
|
Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.
|
Academic Article
|
Severe pulmonary hypertensive diseases: a perspective.
|
Academic Article
|
Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat.
|
Academic Article
|
Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
|
Academic Article
|
Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.
|
Academic Article
|
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
|
Academic Article
|
Vascular endothelial growth factor in pulmonary hypertension.
|
Academic Article
|
A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model.
|
Academic Article
|
Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?
|
Academic Article
|
Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.
|
Academic Article
|
Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.
|
Academic Article
|
Angiogenesis and pulmonary hypertension: a unique process in a unique disease.
|
Academic Article
|
Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection.
|
Academic Article
|
Pulmonary hypertension and inflammation.
|
Academic Article
|
Attenuation of chronic hypoxic pulmonary hypertension by simvastatin.
|
Academic Article
|
Hypoxia induces different genes in the lungs of rats compared with mice.
|
Academic Article
|
Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension.
|
Academic Article
|
Effect of 5-lipoxygenase on the development of pulmonary hypertension in rats.
|
Academic Article
|
Endothelial dysfunction in pulmonary hypertension.
|
Academic Article
|
Circulating endothelial cells in pulmonary hypertension.
|
Academic Article
|
Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.
|
Academic Article
|
One hundred years of research in the pathogenesis of pulmonary hypertension.
|
Academic Article
|
Differential gene expression in chronic hypoxic pulmonary hypertension: effect of simvastatin treatment.
|
Academic Article
|
Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.
|
Academic Article
|
HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.
|
Academic Article
|
Alterations of cellular bioenergetics in pulmonary artery endothelial cells.
|
Academic Article
|
Regression of chronic hypoxic pulmonary hypertension by simvastatin.
|
Academic Article
|
Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.
|
Academic Article
|
Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension.
|
Academic Article
|
Cytoplasmic provenance of STAT3 and PY-STAT3 in the endolysosomal compartments in pulmonary arterial endothelial and smooth muscle cells: implications in pulmonary arterial hypertension.
|
Academic Article
|
Vascular endothelial growth factor of the lung: friend or foe.
|
Academic Article
|
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.
|
Academic Article
|
Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.
|
Academic Article
|
Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.
|
Academic Article
|
Development and pathology of pulmonary hypertension.
|
Academic Article
|
Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques.
|
Academic Article
|
[Pathogenesis of pulmonary hypertension].
|
Academic Article
|
Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective.
|
Academic Article
|
Pulmonary vascular disease associated with parasitic infection--the role of schistosomiasis.
|
Academic Article
|
Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling.
|
Academic Article
|
Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity.
|
Academic Article
|
Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension.
|
Academic Article
|
HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema.
|
Academic Article
|
Gene expression profiles in pulmonary hypertension.
|
Academic Article
|
Significant intrapulmonary Schistosoma egg antigens are not present in schistosomiasis-associated pulmonary hypertension.
|
Academic Article
|
Modern age pathology of pulmonary arterial hypertension.
|
Academic Article
|
Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension.
|
Academic Article
|
Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2a.
|
Academic Article
|
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.
|
Academic Article
|
Expression of human herpesvirus 8 in primary pulmonary hypertension.
|
Academic Article
|
Oxidative stress in severe pulmonary hypertension.
|
Academic Article
|
Oxygen-dependent regulation of pulmonary circulation.
|
Academic Article
|
Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.
|
Academic Article
|
Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus.
|
Academic Article
|
Primary pulmonary arterial hypertension presenting as diffuse micronodules on CT.
|
Academic Article
|
5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.
|
Academic Article
|
Low or absent peptidase expression in plexiform lesions of primary pulmonary hypertension.
|
Academic Article
|
Primary pulmonary hypertension between inflammation and cancer.
|
Academic Article
|
Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension.
|
Academic Article
|
Suppression of type II bone morphogenic protein receptor in vascular smooth muscle induces pulmonary arterial hypertension in transgenic mice.
|
Academic Article
|
Vascular endothelial growth factor in the lung.
|
Academic Article
|
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.
|
Academic Article
|
Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis.
|
Academic Article
|
Microsatellite mutational analysis of endothelial cells within plexiform lesions from patients with familial, pediatric, and sporadic pulmonary hypertension.
|
Academic Article
|
Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension.
|
Academic Article
|
Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.
|
Academic Article
|
Pathologic assessment of vasculopathies in pulmonary hypertension.
|
Academic Article
|
Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension.
|
Academic Article
|
[Pulmonary hypertension: characterization based on the experience of reference centers. ].
|
Academic Article
|
Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.
|
Academic Article
|
Pathology of pulmonary arterial hypertension.
|
Academic Article
|
Pathology of pulmonary hypertension.
|
Academic Article
|
Genomics of pulmonary arterial hypertension: implications for therapy.
|
Academic Article
|
Hypoxia and chronic lung disease.
|
Academic Article
|
Identification of candidate genes in scleroderma-related pulmonary arterial hypertension.
|
Academic Article
|
Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.
|
Academic Article
|
Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension.
|
Academic Article
|
Letter by asosingh et Al regarding article, "circulating endothelial progenitor cells in patients with eisenmenger syndrome and idiopathic pulmonary arterial hypertension".
|
Academic Article
|
Dependence of Golgi apparatus integrity on nitric oxide in vascular cells: implications in pulmonary arterial hypertension.
|
Academic Article
|
Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.
|
Academic Article
|
Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.
|
Academic Article
|
Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease.
|
Concept
|
Hypertension, Pulmonary
|
Concept
|
Hypertension, Portal
|
Academic Article
|
Transforming growth factor-? signaling promotes pulmonary hypertension caused by Schistosoma mansoni.
|
Academic Article
|
Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.
|
Academic Article
|
Pathology of pulmonary hypertension.
|
Academic Article
|
Relevant issues in the pathology and pathobiology of pulmonary hypertension.
|
Academic Article
|
Protective role of IL-6 in vascular remodeling in Schistosoma pulmonary hypertension.
|
Academic Article
|
Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
|
Academic Article
|
Fat and cardiotoxicity in hereditary pulmonary hypertension.
|
Academic Article
|
An official American Thoracic Society Statement: pulmonary hypertension phenotypes.
|
Academic Article
|
Functional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertension.
|
Academic Article
|
Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.
|
Academic Article
|
Role of vascular endothelial growth factor signaling in Schistosoma-induced experimental pulmonary hypertension.
|
Academic Article
|
Progress in solving the sex hormone paradox in pulmonary hypertension.
|
Academic Article
|
How do we measure pathology in PAH (lung and RV) and what does it tell us about the disease.
|
Academic Article
|
The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.
|
Academic Article
|
[Relevant issues in the pathology and pathobiology of pulmonary hypertension].
|
Academic Article
|
Endothelial chromosome 13 deletion in congenital heart disease-associated pulmonary arterial hypertension dysregulates SMAD9 signaling.
|
Academic Article
|
Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition.
|
Academic Article
|
Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake.
|
Academic Article
|
The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.
|
Academic Article
|
Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.
|
Academic Article
|
Pulmonary Veno-occlusive Disease and Pulmonary Hypertension in Dogs: Striking Similarities to the Human Condition.
|
Academic Article
|
Identifying microRNAs targeting Wnt/?-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.
|
Academic Article
|
HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.
|
Academic Article
|
Pulmonary vascular remodeling in pulmonary hypertension.
|
Academic Article
|
Right Ventricle Vasculature in Human Pulmonary Hypertension Assessed by Stereology.
|
Grant
|
Zipcode based nano-imaging of hypertensive pulmonary arteries
|
Grant
|
VEGF PROTECTS AGAINST PULMONARY VASCULAR REMODELING
|
Grant
|
Discovery of biomarkers of pulmonary hypertension
|
Academic Article
|
TGF-? activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
|
Academic Article
|
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
|
Academic Article
|
Redox Regulation of the Superoxide Dismutases SOD3 and SOD2 in the Pulmonary Circulation.
|
Academic Article
|
Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.
|
Academic Article
|
Peroxisome Proliferator-activated Receptor ? and Mitochondria: Drivers or Passengers on the Road to Pulmonary Hypertension?
|
Academic Article
|
Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension.
|
Academic Article
|
Cardiopulmonary remodeling in fattened beef cattle: a naturally occurring large animal model of obesity-associated pulmonary hypertension with left heart disease.
|
Academic Article
|
Paclitaxel blocks Th2-mediated TGF-? activation in Schistosoma mansoni-induced pulmonary hypertension.
|
Academic Article
|
Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome.
|
Concept
|
Familial Primary Pulmonary Hypertension
|
Academic Article
|
IL-6Ra in Smooth Muscle Cells Protects against Schistosoma- and Hypoxia-induced Pulmonary Hypertension.
|
Academic Article
|
Pulmonary Arteries and Microcirculation in?COPD With Pulmonary Hypertension: Bystander or Culprit?
|
Academic Article
|
Th2 CD4+ T Cells Are Necessary and Sufficient for Schistosoma-Pulmonary Hypertension.
|
Academic Article
|
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.
|
Academic Article
|
Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension.
|
Academic Article
|
Pluripotent hematopoietic stem cells augment a-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension.
|
Academic Article
|
Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment.
|
Academic Article
|
Publisher Correction: Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment.
|
Academic Article
|
Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal.
|
Academic Article
|
Endothelial cell PHD2-HIF1a-PFKFB3 contributes to right ventricle vascular adaptation in pulmonary hypertension.
|
Academic Article
|
Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension.
|
Academic Article
|
Experimental Schistosoma japonicum-induced pulmonary hypertension.
|
Academic Article
|
Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform.
|
Academic Article
|
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension.
|
Academic Article
|
Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension.
|
Academic Article
|
The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension.
|
Academic Article
|
Integrative Multiomics to Dissect the Lung Transcriptional Landscape of Pulmonary Arterial Hypertension.
|
Academic Article
|
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.
|
Academic Article
|
The Effect of Hypoxia-inducible Factor Inhibition on the Phenotype of Fibroblasts in Human and Bovine Pulmonary Hypertension.
|
Academic Article
|
Repetitive schistosoma exposure causes perivascular lung fibrosis and persistent pulmonary hypertension.
|
Academic Article
|
SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.
|